Genesis Biomedical^LTD has substantial Intellectual Capital across a number of medical technologies. The Company has developed core capabilities around proprietary software-based smart card management systems. Applications include the coding, capture, documentation and remote site digital transmission of medically critical information such as treatment prescriptions, product and process validation. This enables compliance with health authorities requirements for evidence and documentation based care.

Genesis recognises that it has important stakeholder relationships with the medical and health professions, strategic partner companies and its own stakeholders.

These partnerships provide the technology and resources required to achieve our mission of restoring and maintaining the quality of life of the most important stakeholder group, those people affected by musculoskeletal disorders.

The Company's core technologies include smart card controlled and internet enabled innovations for the biomedical market. Genesis has developed its own technology portfolio of products and processes and uses partnering to share in the benefits of providing these innovations to ensure competitive advantage in related fields.

Through this partnering Genesis has become active in the areas of rehabilitation therapies, orthopaedic bracing and tissue engineering.